Published: 09/02/2021 22:54 GMT Supernus Pharmaceuticals Inc (SUPN) - Supernus Announces Qelbree™ Snda for Adult Indication Accepted for Review by FDA.
Supernus Pharmaceuticals Inc - Snda is Now Considered Filed, With a User Fee Goal Date (pdufa Date) of April 29, 2022 .
